Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review

Date: April 15, 2014
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: AB40CEC6D43EN
Leaflet:

Download PDF Leaflet

Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review
Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Access Pharmaceuticals, Inc., (Access) is a biopharmaceutical company. It develops novel medicines for the treatment of cancer and supportive care of cancer patients. The company’s product MuGard for the management of patients with mucositis is approved in the US, EU, China and South Korea. The company also three products in preclinical development which are based on its drug delivery technologies. The company’s advanced drug delivery technologies include mucoadhesive hydrogel technology, CobaCyte-mediated targeted delivery technology and CobOral, a preclinical nanopolymer oral drug delivery technology based on the natural vitamin B12 oral uptake mechanism.

Access Pharmaceuticals, Inc. Key Recent Developments

Mar 26, 2014: Access Pharmaceuticals Cobraxane Offers Enhanced Tumor Growth Inhibition In Tumor Models
Mar 21, 2014: Access Pharmaceuticals Advances Development of ProctiGard for Radiation Proctitis
Jul 26, 2013: Access Pharmaceuticals To Host Investor Call On Wednesday, July 31, 2013
May 16, 2013: Access Pharma Reports Revenue Of $1.2m In Q1 2013
Mar 19, 2013: Access Pharma Reports Revenue Of $4.4m In 2012

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Access Pharmaceuticals, Inc. - Key Facts
Access Pharmaceuticals, Inc. - Key Employees
Access Pharmaceuticals, Inc. - Key Employee Biographies
Access Pharmaceuticals, Inc. - Major Products and Services
Access Pharmaceuticals, Inc. - Pharmaceutical Pipeline Products Data
Access Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Access Pharmaceuticals, Inc., Pipeline Products by Development Phase
Access Pharmaceuticals, Inc. - History
Access Pharmaceuticals, Inc. - Company Statement
Access Pharmaceuticals, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Access Pharmaceuticals, Inc. - Business Description
Access Pharmaceuticals, Inc. - SWOT Analysis
SWOT Analysis - Overview
Access Pharmaceuticals, Inc. - Strengths
Strength - Proprietary Drug Delivery Technologies
Strength - Research and Development activities
Strength - Strong Patent Portfolio
Strength - Marketed product, MuGard
Access Pharmaceuticals, Inc. - Weaknesses
Weakness - Weak Profitability Position
Access Pharmaceuticals, Inc. - Opportunities
Opportunity - Strategic Agreements
Opportunity - Growth in Radiation Therapy Market
Opportunity - Market potential – Cancer Treatments
Access Pharmaceuticals, Inc. - Threats
Threat - Uncertain R&D Outcomes
Threat - Tightening of FDA’s Regulatory Oversight
Threat - Competition
Access Pharmaceuticals, Inc. - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Access Pharmaceuticals, Inc., Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Access Pharmaceuticals, Inc., Recent Developments
Mar 26, 2014: Access Pharmaceuticals Cobraxane Offers Enhanced Tumor Growth Inhibition In Tumor Models
Mar 21, 2014: Access Pharmaceuticals Advances Development of ProctiGard for Radiation Proctitis
Jul 26, 2013: Access Pharmaceuticals To Host Investor Call On Wednesday, July 31, 2013
May 16, 2013: Access Pharma Reports Revenue Of $1.2m In Q1 2013
Mar 19, 2013: Access Pharma Reports Revenue Of $4.4m In 2012

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Access Pharmaceuticals, Inc., Key Facts
Access Pharmaceuticals, Inc., Key Employees
Access Pharmaceuticals, Inc., Key Employee Biographies
Access Pharmaceuticals, Inc., Major Products and Services
Access Pharmaceuticals, Inc., Number of Pipeline Products by Therapy Area
Access Pharmaceuticals, Inc., Number of Pipeline Products by Development Stage
Access Pharmaceuticals, Inc., Pipeline Products By Therapy Area and Development Phase
Access Pharmaceuticals, Inc., History
Access Pharmaceuticals, Inc., Subsidiaries
Access Pharmaceuticals, Inc., Key Competitors
Access Pharmaceuticals, Inc., Ratios based on current share price
Access Pharmaceuticals, Inc., Annual Ratios
Access Pharmaceuticals, Inc., Interim Ratios
Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2008 to YTD 2014
Access Pharmaceuticals, Inc., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Access Pharmaceuticals, Inc., Pipeline Products by Therapy Area
Access Pharmaceuticals, Inc., Pipeline Products by Development Phase
Access Pharmaceuticals, Inc., Performance Chart (2009 - 2013)
Access Pharmaceuticals, Inc., Ratio Charts
Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2008 to YTD 2014
Access Pharmaceuticals, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2008 to YTD 2014
Skip to top


Ask Your Question

Access Pharmaceuticals, Inc. (ACCP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: